Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
atenolol 5 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
dikoboltedetat 300 mg/20 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dikoboltedetat 300 mg/20 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin beta 4 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
epoetin beta 4 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fentanyl (som fentanylcitrat) 500 mikrogram/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fentanyl (som fentanylcitrat) 500 mikrogram/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
atosiban (som atosibanacetat) 37,5 mg/5 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
atosiban (som atosibanacetat) 37,5 mg/5 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
amoxicillin (som amoxicillintrihydrat) 80 milligram/milliliter och klavulansyra (som kaliumklavulanat) 11,4 milligram/milliliter, oral suspension |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
amoxicillin (som amoxicillintrihydrat) 80 milligram/milliliter och klavulansyra (som kaliumklavulanat) 11,4 milligram/milliliter, oral suspension |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
digoxin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
digoxin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
atosiban (som atosibanacetat) 6,75 mg/0,9 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
atosiban (som atosibanacetat) 6,75 mg/0,9 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 20 mg/0,2 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
enoxaparinnatrium 20 mg/0,2 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
prometazinhydroklorid 25 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
prometazinhydroklorid 25 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 100 mg/5 ml injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 100 mg/5 ml injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fondaparinuxnatrium 7,5 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
fondaparinuxnatrium 7,5 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
tropisetron (som tropisetronhydroklorid) 2 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
tropisetron (som tropisetronhydroklorid) 2 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hydromorfonhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
hydromorfonhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
tropisetron (som tropiseronhydroklorid) 5 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
tropisetron (som tropiseronhydroklorid) 5 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
noradrenalin (som noradrenalinbitartrat) 2 mg/2 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
noradrenalin (som noradrenalinbitartrat) 2 mg/2 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
hydromorfonhydroklorid 2 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hydromorfonhydroklorid 2 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 200 mg/20 ml, injektionsvätska, emulsion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 200 mg/20 ml, injektionsvätska, emulsion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
laxkalcitonin 50 enheter/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
laxkalcitonin 50 enheter/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metotrexat (som metotrexatnatrium) 5 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metotrexat (som metotrexatnatrium) 5 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
noretindronenantat 200 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
noretindronenantat 200 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
heparinnatrium 25 000 enheter/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
heparinnatrium 25 000 enheter/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 500 mg/50 ml, injektionsvätska, emulsion, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 500 mg/50 ml, injektionsvätska, emulsion, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
panitumumab 100 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
panitumumab 100 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
vinkristinsulfat 1 mg/ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
vinkristinsulfat 1 mg/ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hydroxiprogesteronkaproat 250 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
hydroxiprogesteronkaproat 250 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
linezolid 600 mg/300 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
linezolid 600 mg/300 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fondaparinuxnatrium 2,5 mg/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
fondaparinuxnatrium 2,5 mg/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
vinkristinsulfat 2 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
vinkristinsulfat 2 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
doxorubicinhydroklorid 20 mg/10 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
doxorubicinhydroklorid 20 mg/10 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som humant lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
humant insulin (som humant lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
2 |
papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
vinkristinsulfat 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
vinkristinsulfat 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
levobupivakain (som levobupivakainhydroklorid) 25 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
levobupivakain (som levobupivakainhydroklorid) 25 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 1 g/50 ml, injektionsvätska, emulsion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
propofol 1 g/50 ml, injektionsvätska, emulsion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
doxorubicinhydroklorid 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
doxorubicinhydroklorid 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
metotrexat (som metotrexatnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
metotrexat (som metotrexatnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
oktreotid (som oktreotidacetat) 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
propranololhydroklorid 1 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
propranololhydroklorid 1 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |